HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High Risk Percutaneous Coronary Intervention of Left Main Bifurcation Stenosis in a Peritoneal Dialysis Patient.

Abstract
Complex coronary artery disease is the leading cause of death in patients with end-stage renal disease. We report a case of a patient on peritoneal dialysis, preloaded with Prasugrel and acetylsalicylic acid as а potent dual antiplatelet therapy (DAPT). The patient underwent a high-risk percutaneous coronary intervention (PCI) due to bifurcation stenosis of the left main stem branch. A "double kiss crush" bifurcation stenting technique was performed. This case provides additional data about the treatment of this group of patients, a group that is often excluded from randomized control trials, but is frequently encountered in cardiovascular practice. Furthermore, it helps to advance PCI treatment along with exploring the safety of potent DAPT in a group that is susceptible to both ischemia and bleeding, thus presenting a great challenge in the decision for treatment.
AuthorsOliver Bushljetikj, Biljana Zafirovska Taleska, Zhan Zimbakov, Frosina Arnaudova Dezulovic, Irena Rambabova-Bushljetik, Goce Spasovski
JournalPrilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) (Pril (Makedon Akad Nauk Umet Odd Med Nauki)) Vol. 42 Issue 2 Pg. 71-78 (Oct 26 2021) ISSN: 1857-8985 [Electronic] North Macedonia
PMID34699707 (Publication Type: Case Reports, Journal Article)
Copyright© 2021 Oliver Bushljetikj et al., published by Sciendo.
Topics
  • Constriction, Pathologic
  • Drug-Eluting Stents
  • Humans
  • Percutaneous Coronary Intervention (adverse effects)
  • Peritoneal Dialysis
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: